Events Archives - Page 52 of 287

MondayJun 17, 2019 11:31 am

B. Riley FBR Consumer & Media Conference to Shine Spotlight on Select Small- and Mid-Cap Companies

The end of summer often represents a beginning for the investment world. In particular, the Annual B. Riley FBR Consumer & Media Conference will be shining the spotlight on a set of select small- and mid-cap companies. On October 3, 2019, the invitation-only conference will offer companies in the consumer and media space an opportunity to present to qualified institutional investors through presentations, fireside chats and private meetings. Attendees are expected to include senior management teams from approximately 60 companies across the consumer, leisure and media sectors, as well as more than 400 professionals from the firm’s network of institutional…

ThursdayJun 13, 2019 9:00 am

Increasing Demand for Batteries Strengthens Worldwide Nickel Market

NetworkNewsWire Editorial Coverage: Growth in demand for batteries is pushing up nickel production around the world. Nickel is an essential component in batteries, including those for cars and phones. Demand for metals is growing, especially in China, a major battery manufacturer. Indonesia is the world’s largest nickel producer. The country is working to expand its manufacturing sector. Pacific Rim Cobalt Corporation (CSE: BOLT) (OTCQB: PCRCF) (PCRCF Profile) is making the most of Indonesian nickel through an aggressive exploration and development program there. Ivanhoe Mines Ltd. (TSX: IVN) (OTCQX: IVPAF) has announced mine development is underway at its platinum-group metals, nickel,…

TuesdayJun 11, 2019 10:56 am

INmune Bio Inc. (NASDAQ: INMB) Focusing on New Immunotherapies that Reprogram Immune Systems

INmune Bio is at the vanguard of reprogramming the innate immune system for the treatment of disease The company’s focus is on modulating components of the innate immune system to treat cancer and Alzheimer’s disease INmune Bio’s drug candidates include INKmune, INB03 and XPro1595 INmune Bio Inc. (NASDAQ: INMB) is a diversified, clinical-stage biotechnology company headquartered in La Jolla, California. The company is hoping to develop new immunotherapies that reprogram patients’ innate immune systems to allow the immune systems to fight cancer and Alzheimer’s disease. INmune drug candidates INKmune and INB03 may be used to treat cancer, while XPro1595 targets…

TuesdayJun 11, 2019 9:00 am

Swelling Battery Demand Keeps Indonesian Nickel Sector Strong

NetworkNewsWire Editorial Coverage: Growth in demand for batteries is pushing up nickel production and economic change in Indonesia. Nickel is an essential component in batteries, including those for cars and phones. Demand for metals is growing, most importantly in China, a major battery manufacturer. Indonesia is the world’s largest nickel producer. The country is working to expand its manufacturing sector, attracting investment from multinational industry and mining giants. Pacific Rim Cobalt Corporation (OTCQB: PCRCF) (CSE: BOLT) (PCRCF Profile) is making the most of Indonesian nickel through an aggressive exploration and development program there. VALE S.A. (NYSE: VALE), the world’s leading…

MondayJun 10, 2019 12:27 pm

XLIVE Esports Summit to Shine Spotlight on Firms and Forces Shaping the Sector

If you want to know why the global esports market is set to hit $1.1 billion in revenues in 2019, then join the hundreds who are expected to attend the upcoming XLIVE Esports Summit, scheduled for June 25-27, 2019, at Hudson Loft in downtown Los Angeles. You’ll find the answer to that question and many others at the conference as you listen to a wave of keynote speakers that includes Mario Pacini of Walmart (NYSE: WMT), Lovell Walker of MGM Resorts International (NYSE: MGM), Mike Kinney of the Children’s Miracle Network, Ryan Ruden of Columbia Records, Justin Varghese of DreamHack, Chris Mann of NRG Esports,…

MondayJun 10, 2019 12:08 pm

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Releases Q1 Results, Begins Trading on OTCQX Best Market

The company maintains the top two best-selling edible cannabis products in California Plus is working to make cannabis safe and approachable for all The company recently reported a 4.9 percent increase in sales over Q4 2018, bringing Q1 2019 retail sales to $10.84 million Plus recently commenced trading on the OTCQX Best Market Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) recently released its unaudited first quarter 2019 results (http://nnw.fm/vX4Bb). As the edibles’ share of the cannabis market continues to grow, PLUS is well positioned to lead the way in the branded products space. The company is one of the fastest-growing…

MondayJun 10, 2019 11:21 am

Hemptown USA Leveraging Leading Genetics to Increase Yields and Expand into Novel Cannabinoids

Hemp seed genetics are critical to hemp farming success Cannabigerol (CBG) is emerging as a valuable cannabinoid with multiple potential health benefits Hemptown USA is growing one million rare cannabigerol-dominant plants designed to yield up to one million pounds of CBG biomass High quality seeds are a key prerequisite for growing healthy, strong cannabis plants. The right seeds can deliver the right cannabinoid profile, increase resilience and help for achieving sufficiently sustainable yields. Companies like Hemptown USA are pioneers in the farming of novel cannabinoid strains in addition to cannabidiol (CBD). In 2019, the company acquired $5.5 million worth of…

WednesdayJun 05, 2019 3:40 pm

CytoDyn Inc. (CYDY) Starts Presentation at 9th Annual LD Micro Invitational

CytoDyn (OTCQB: CYDY) is a biotechnology company developing innovative treatments for multiple therapeutic indications based on PRO 140 (leronlimab), a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 plays a key role in the ability of HIV to enter and infect healthy T-cells. The CCR5 receptor is also implicated in tumor metastasis and in immune-mediated illnesses such as graft-vs-host disease (GvHD) and NASH. CytoDyn has successfully completed a Phase 3 pivotal trial with PRO 140 in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients. The company plans to seek FDA approval for PRO 140 in combination therapy and…

WednesdayJun 05, 2019 3:40 pm

Eastside Distilling Inc. (NASDAQ: EAST) Starts Presentation at 9th Annual LD Micro Invitational

Eastside Distilling (NASDAQ: EAST) has been producing high-quality, award-winning craft spirits since 2008. The company is distinguished by its highly decorated product lineup that includes Burnside Bourbon, West End American Whiskey, Goose Hollow Reserve, Below Deck Rums, Portland Potato Vodka, Hue-Hue Coffee Rum and a distinctive line of fruit infused spirits. Eastside Distilling is majority owner of Big Bottom and the Redneck Riviera Whiskey Co. All Eastside, Big Bottom and Redneck Riviera spirits are crafted from natural ingredients for quality and taste. Eastside’s Mother Lode Bottling subsidiary is one of the Northwest’s leading independent spirit bottlers and ready-to-drink canners. For…

WednesdayJun 05, 2019 3:00 pm

Wize Pharma Inc. (WIZP) Starts Presentation at 9th Annual LD Micro Invitational

Wize Pharma (OTCQB: WIZP) is a clinical-stage biopharmaceutical company currently focused on the treatment of ophthalmic disorders, including DES. Wize has in-licensed certain rights to purchase, market, sell and distribute a formula known as LO2A, a drug developed for the treatment of DES, and other ophthalmological illnesses, including CCh and Sjögren's syndrome (Sjögren's). Wize's strategy involves engaging local or multinational distributors to handle the distribution of LO2A. Wize has finished a Phase II trial of LO2A for patients with CCH and is currently conducting a phase IV study for LO2A for DES in patients with Sjögren's. For more information, visit…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Category: Events